In liver cancer, IGFBP7 induces anti-tumor effects by binding to the IGF1 receptor (IGF1R) to inhibit IGF signaling [25]; in colon cancer, IGFBP7 down-regulates EMT to promote liver metastasis [26]. This evidence concerns the gene IGF1 and neoplasm.